Effect of in vivo administration of reprogramming factors in the mouse liver.
Tomokuni A, Eguchi H, Hoshino H, Dewi DL, Nishikawa S, Kano Y, Miyoshi N, Tojo A, Kobayashi S, Gotoh N, Hinohara K, Fusaki N, Saito T, Suemizu H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Doki Y, Mori M, Ishii H, Nagano H.
Tomokuni A, et al.
Oncol Lett. 2013 Aug;6(2):323-328. doi: 10.3892/ol.2013.1418. Epub 2013 Jun 20.
Oncol Lett. 2013.
PMID: 24137324
Free PMC article.